|
1) Yoshida K, Toki F, Takeuchi T, et al. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci. 1995; 40: 1561-8
|
|
|
|
2) Kawaguchi K, Koike M, Tsuruta K, et al. Lymphoplasmacytic sclerosing pancreatitis with cholangitis: a variant of primary sclerosing cholangitis extensively involving pancreas. Hum Pathol. 1991; 22: 387-95
|
|
|
|
|
|
3) Ectors N, Maillet B, Aerts R, et al. Non-alcoholic duct destructive chronic pancreatitis. Gut. 1997; 41: 263-8
|
|
|
|
|
|
4) Notohara K, Burgart LJ, Yadav D, et al. Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration. Clinicopathologic features of 35 cases. Am J Surg Pathol. 2003; 27: 1119-27
|
|
|
|
|
|
5) Zamboni G, Lüttges J, Capelli P, et al. Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch. 2004; 445: 552-63
|
|
|
|
|
|
6) Deshpande V, Chiocca S, Finkelberg D, et al. Autoimmune pancreatitis: a systemic immune complex mediated disease. Am J Surg Pathol. 2006; 30: 1537-45
|
|
|
|
|
|
7) Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001; 344: 732-8
|
|
|
|
|
|
8) Hamano H, Kawa S, Ochi Y, et al. Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet. 2002; 359: 1403-4
|
|
|
|
|
|
9) Kamisawa T, Funata N, Hayashi Y. Lymphoplasmacytic sclerosing pancreatitis is a pancreatic lesion of IgG4-related systemic disease. Am J Surg Pathol. 2004; 28: 1114
|
|
|
|
|
|
10) Zhang L, Notohara K, Levy MJ, et al. IgG4-positive plasma cell infiltration in the diagnosis of autoimmune pancreatitis. Mod Pathol. 2007; 20: 23-8
|
|
|
|
|
|
11) Sah RP, Chari ST, Pannala R, et al. Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. Gastroenterology. 2010; 139: 140-8
|
|
|
|
|
|
12) Chari ST, Kloeppel G, Zhang L, et al. Histopathologic and clinical subtypes of autoimmune pancreatitis: the Honolulu consensus document. Pancreas. 2010; 39: 549-54
|
|
|
|
|
|
13) Sugumar A, Klöppel G, Chari ST. Autoimmune pancreatitis: pathologic subtypes and their implications for its diagnosis. Am J Gastroenterol. 2009; 104: 2308-10
|
|
|
|
|
|
14) Klöppel G, Detlefsen S, Chari ST, et al. Autoimmune pancreatitis: the clinicopathological characteristics of the subtype with granulocytic epithelial lesions. J Gastroenterol. 2010; 45: 787-93
|
|
|
|
|
|
15) 厚生労働省難治性膵疾患調査研究班・日本膵臓学会. 自己免疫性膵炎診療ガイドライン2009. 膵臓. 2009; 24 (suppl): 15-17
|
|
|
|
|
|
16) Okazaki K, Kawa S, Kamisawa T, et al. Japanese clinical guidelines for autoimmune pancreatitis. Pancreas. 2009; 38: 849-66
|
|
|
|
|
|
17) Okazaki K, Kawa S, Kamisawa T, et al. Japanese consensus guidelines for management of autoimmune pancreatitis: I. Concept and diagnosis of autoimmune pancreatitis. J Gastroenterol. 2010; 45: 249-65
|
|
|
|
|
|
18) Kamisawa T, Funata N Hayashi Y, et al. Close relationship between autoimmune pancreatitis and multifocal fibrosclerosis. Gut. 2003; 52: 683-7
|
|
|
|
|
|
19) Witkiewicz AK, Kennedy EP, Kennyon L, et al. Synchronous autoimmune pancreatitis and infiltrating pancreatic ductal adenocarcinoma: case report and review of the literature. Hum Pathol. 2008; 39: 1548-51
|
|
|
|
|
|
20) Motosugi U, Ichikawa T, Yamaguchi H, et al. Small invasive ductal adenocarcinoma of the pancreas associated with lymphoplasmacytic sclerosing pancreatitis. Pathol Int. 2009; 59: 744-7
|
|
|
|
|
|
21) Kamisawa T, Chen PY, Tu Y, et al. Pancreatic cancer with a high serum IgG4 concentration. World J Gastroenterol. 2006; 12: 6225-8
|
|
|
|
|
|
22) Ghazale A, Chari ST, Smyrk TC, et al. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol. 2007; 102: 1646-53
|
|
|
|
|
|
23) 能登原憲司. 特集: 自己免疫性膵炎. 病理. 臨牀消化器内科. 2010; 25: 1225-31
|
|
|
|
|
|
24) Okazaki K, Kawa S, Kamisawa T, et al. Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol. 2006; 41: 626-31
|
|
|
|
|
25) Shimosegawa T, Kanno A. Autoimmune pancreatitis in Japan: overview and perspective. J Gastroenterol. 2009; 44: 503-17
|
|
|
|
|
|
26) Kawa S, Okazaki K, Kamisawa T, et al. Japanese consensus guidelines for management of autoimmune pancreatitis: II. Extrapancreatic lesions, differential diagnosis. J Gastroenterol. 2010; 45: 355-69
|
|
|
|
|
|
27) Kamisawa T, Okazaki K, Kawa S, et al. Japanese consensus guidelines for management of autoimmune pancreatitis: III. Treatment and prognosis of AIP. J Gastroenterol. 2010; 45: 471-7
|
|
|
|
|
|
28) Kamisawa T, Notohara K, Shimosegawa T. Two clinicopathologic sutypes of autoimmune pancreatitis: LPSP and IDCP. Gastroenterology. 2010; 139: 22-5
|
|
|
|
|
|
29) 神澤輝実. 諸外国における自己免疫性膵炎の捉え方. 膵臓. 2007; 22: 672-6
|
|
|
|
|
30) 能登原憲司. 自己免疫性膵炎の病理: 日本と欧米との違い. 膵臓. 2009; 24: 479-84
|
|
|
|
|
|
31) Detlefsen S, Drewes AM, Vyberg M, et al. Diagnosis of autoimmune pancreatitis by core needle biopsy: application of six microscopic criteria. Virchows Arch. 2009; 454: 531-9
|
|
|
|
|
|
32) Frulloni L, Lunardi C, Simone R, et al. Identification of a novel antibody associated with autoimmune pancreatitis. N Engl J Med. 2009; 361: 2135-42
|
|
|
|
|
|
33) Löhr JM, Faissner R, Koczan D, et al. Autoantibodies against the exocrine pancreas in autoimmune pancreatitis: gene and protein expression profiling and immunoassays identify pancreatic enzymes as a major target of the inflammatory process. Am J Gastroenterol. 2010; 105: 2060-71
|
|
|
|
|
|
34) Frulloni L, Scattolini C, Falconi M, et al. Autoimmune pancreatitis: differences between the focal and diffuse forms in 87 patients. Am J Gastroenterol. 2009; 104: 2288-94
|
|
|
|
|